Update shared on05 Sep 2025
With no changes observed in either Ensign Group’s future P/E ratio or net profit margin, the consensus analyst price target remains stable at $174.67.
What's in the News
- Ensign Group settled a whistleblower lawsuit for over $47.3 million, resolving allegations of nationwide Medicare and Medicaid fraud, kickbacks, and violations of federal and state laws, as well as breaching a prior Corporate Integrity Agreement.
- The company made multiple acquisitions, including Pine Crest Health and Memory Care in Wisconsin, Crystal Heights Care Center in Iowa, and Timber Springs Transitional Care in Idaho; in California, Ensign-affiliates now operate eleven new skilled nursing and assisted living facilities, adding over 1,200 beds/units.
- Ensign, via its captive REIT, Standard Bearer Healthcare, also acquired real estate in Texas and continues to expand its owned and operated facility portfolio, now spanning 348 healthcare operations in 17 states.
- The company raised 2025 earnings guidance to $6.34–$6.46 per diluted share and revenue guidance to $4.99–$5.02 billion, reflecting strong performance and anticipated acquisitions.
- Ensign announced a $20 million share repurchase program valid for 12 months beginning June 16, 2025, but had not executed any repurchases through June 30, 2025.
Valuation Changes
Summary of Valuation Changes for Ensign Group
- The Consensus Analyst Price Target remained effectively unchanged, at $174.67.
- The Future P/E for Ensign Group remained effectively unchanged, at 25.36x.
- The Net Profit Margin for Ensign Group remained effectively unchanged, at 7.47%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.